The Clinical Research Department at BC Cancer was established to be the central point of contact for investigators wanting to undertake clinical research at BC Cancer. 

The goals of the department are to improve the quality and productivity of clinical research at BC Cancer while encouraging a culture of innovation, responsibility and accountability.  The Clinical Research Department is committed to ensuring BC Cancer clinical research is operationally efficient and of high quality.  We will achieve this by standardizing practices across the province, providing comprehensive education programs and quality and metrics reporting and administrative support for clinician-investigators.

From Research to Treatment

Many of the treatments we have in Canada today are available thanks to people who volunteer to take part in a clinical trial​.  

News & Events

New national survey study aims to improve equity in Canadian cancer clinical trials

A new Canadian Cancer Trials Group (CCTG) survey study, SC32S, has opened across Canada to collect sociodemographic data from cancer clinical trial participants and assess whether asking questions about this information feels appropriate to patients. The patient survey will ask CCTG trial participants about different parts of everyday life that can affect patient health and experience with cancer care.

Recent Publications

Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial.

Nat Med 2025
Usmani SZ, Facon T, Hungria V, Bahlis NJ, Venner CP, Braunstein M, Pour L, Martí JM, Basu S, Cohen YC, Matsumoto M, Suzuki K, Hulin C, Grosicki S, Legiec W, Beksac M, Maiolino A, Takamatsu H, Perrot A, Turgut M, Ahmadi T, Liu W, Wang J, Chastain K, Vermeulen J, Krevvata M, Lopez-Masi L, Carey J, Rowe M, Carson R, Zweegman S.
Back to top